Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy.
Knudson KM, Hwang S, McCann MS, Joshi BH, Husain SR, Puri RK. Knudson KM, et al. Front Immunol. 2022 Apr 8;13:878365. doi: 10.3389/fimmu.2022.878365. eCollection 2022. Front Immunol. 2022. PMID: 35464460 Free PMC article. Review.
Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer.
Gatti-Mays ME, Gameiro SR, Ozawa Y, Knudson KM, Hicks KC, Palena C, Cordes LM, Steinberg SM, Francis D, Karzai F, Lipkowitz S, Donahue RN, Jochems C, Schlom J, Gulley JL. Gatti-Mays ME, et al. Among authors: knudson km. Front Oncol. 2021 Mar 5;10:581801. doi: 10.3389/fonc.2020.581801. eCollection 2020. Front Oncol. 2021. PMID: 33747894 Free PMC article.
Rationale for IL-15 superagonists in cancer immunotherapy.
Knudson KM, Hodge JW, Schlom J, Gameiro SR. Knudson KM, et al. Expert Opin Biol Ther. 2020 Jul;20(7):705-709. doi: 10.1080/14712598.2020.1738379. Epub 2020 Mar 11. Expert Opin Biol Ther. 2020. PMID: 32159390 No abstract available.
IL-12 Signals through the TCR To Support CD8 Innate Immune Responses.
Goplen NP, Saxena V, Knudson KM, Schrum AG, Gil D, Daniels MA, Zamoyska R, Teixeiro E. Goplen NP, et al. Among authors: knudson km. J Immunol. 2016 Sep 15;197(6):2434-43. doi: 10.4049/jimmunol.1600037. Epub 2016 Aug 12. J Immunol. 2016. PMID: 27521342 Free PMC article.
Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types.
Hicks KC, Fantini M, Donahue RN, Schwab A, Knudson KM, Tritsch SR, Jochems C, Clavijo PE, Allen CT, Hodge JW, Tsang KY, Schlom J, Gameiro SR. Hicks KC, et al. Among authors: knudson km. Oncoimmunology. 2018 Jul 30;7(11):e1466018. doi: 10.1080/2162402X.2018.1466018. eCollection 2018. Oncoimmunology. 2018. PMID: 30377559 Free PMC article.
The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex.
Jochems C, Tritsch SR, Knudson KM, Gameiro SR, Smalley Rumfield C, Pellom ST, Morillon YM, Newman R, Marcus W, Szeto C, Rabizadeh S, Wong HC, Soon-Shiong P, Schlom J. Jochems C, et al. Among authors: knudson km. Oncoimmunology. 2018 Nov 27;8(2):e1532764. doi: 10.1080/2162402X.2018.1532764. eCollection 2019. Oncoimmunology. 2018. PMID: 30713787 Free PMC article.
21 results